Study examines financial sustainability of affordable housing-with-services models for older adults

Insights from the Boston Right Care, Right Place, Right Time (R3) Healthcare and Housing Program

2023-10-31

(Press-News.org) A groundbreaking study published in the journal Research in Aging sheds light on the financial challenges of housing-with-health-services models for low-income older adults. The report explores strategies for ensuring the sustainability of these beneficial efforts.

The study was conducted in partnership with Hebrew SeniorLife, a Harvard Medical School-affiliated nonprofit organization serving older adults in the Greater Boston area. It drew on insights from 31 key informational interviews and three focus groups with payers, housing providers, and community partners.

The Right Care, Right Place, Right Time (R3) Program deploys wellness teams in affordable housing sites. These teams include coordinators and nurses who adopt an “eyes-on” approach, training all housing staff to observe and contribute to care coordination for residents. The teams bridge housing and healthcare efforts, supporting residents where they live and aiming for better health outcomes and prolonged independence.

Despite the recognized potential of these programs to enhance the lives of low-income older adults, finding reliable funding sources is a significant hurdle.

Key findings from the study, “Promoting Sustainability in Housing with Services: Insights from the Right Care, Right Place Right Time Program,” include the following:

Recognized Value: Participants unanimously recognized the value of housing-with-services programs in improving the well-being of older adults. Funding Need: There was little consensus on how to secure ongoing funding for these programs. The responsibility for individuals in housing sites is distributed across health insurers, hospitals, and community service providers, making it challenging to incentivize investment. Government’s Role: The study suggests that governmental mechanisms, possibly at the federal level, are needed to channel funding toward supportive services. Without reliable funding sources, replicating these housing models for low-income older people will be difficult. “The study emphasizes the need for innovative solutions to secure funding for supportive services,” said co-author Marc A. Cohen, co-director, LeadingAge LTSS Center, Department of Gerontology, University of Massachusetts. “Sustaining and financing these models has proven to be a complex issue, given the separate systems of publicly-funded housing and healthcare,” he said.

Housing models that integrate supportive services have proven popular among better-off individuals who can afford private-pay environments. Yet options for older people with fewer resources have remained limited due to scarce public financing. The Section 202 low-income housing program, established by the U.S. Department of Housing and Urban Development, has been one option for affordable housing for people aged 62 and older. Service coordinators were added to the program in 1990; yet it has remained limited in scope and poorly funded over the years, leaving many older adults without access to supportive housing environments.

“We expect these findings to contribute to a broader understanding of how housing-with-services models can be developed and maintained to benefit low-income older adults,” said Kim Brooks, chief operating officer, senior living, Hebrew SeniorLife.

The study examined the experiences and perspectives of individuals involved in the Boston-area Right Care, Right Place, Right Time Program, which enrolled 400 older adults across seven intervention sites. Four sites were operated by Hebrew SeniorLife and three were operated by partner providers, including Milton Residences for the Elderly and WinnCompanies.

Lead author of the study was Pamela Nadash, PhD, associate professor, Gerontology Department, University of Massachusetts. Co-authors include Edward Alan Miller, professor and chair, Department of Gerontology, University of Massachusetts; Elizabeth J. Simpson, MPH, Department of Gerontology, University of Massachusetts; Molly Wylie, Department of Gerontology, University of Massachusetts; Natalie Shellito, Department of Gerontology, University of Massachusetts; Yan Lin, Department of Gerontology, University of Massachusetts; Taylor Jansen, PhD, Department of Gerontology, University of Massachusetts; and Marc A. Cohen, co-director, LeadingAge LTSS Center, Department of Gerontology, University of Massachusetts and Center for Consumer Engagement and Health System Transformation, Community Catalyst.

This work was supported by Hebrew SeniorLife, which designed and piloted the R3 program and secured additional funding for the evaluation and intervention. Funders include the Commonwealth of Massachusetts Health Policy Commission Health Care Innovation Investment Program; Beacon Communities LLC; Boston Scientiﬁc Foundation; Coverys Community Healthcare Foundation; Enterprise Community Partners; Massachusetts Department of Housing and Community Development; Mass Housing; and The Pioneer Institute.

About Hebrew SeniorLife
Hebrew SeniorLife, an affiliate of Harvard Medical School, is a national senior services leader uniquely dedicated to rethinking, researching, and redefining the possibilities of aging. Hebrew SeniorLife cares for more than 4,500 seniors a day across six campuses throughout Greater Boston. Locations include: Hebrew Rehabilitation Center-Boston and Hebrew Rehabilitation Center-NewBridge in Dedham; NewBridge on the Charles, Dedham; Orchard Cove, Canton; Simon C. Fireman Community, Randolph; Center Communities of Brookline, Brookline; and Jack Satter House, Revere. Founded in 1903, Hebrew SeniorLife also conducts influential research into aging at the Hinda and Arthur Marcus Institute for Aging Research, which has a portfolio of more than $85 million, making it one of the largest gerontological research facilities in the U.S. in a clinical setting. It also trains more than 1,000 geriatric care providers each year. For more information about Hebrew SeniorLife, visit our website or follow us on our blog, Facebook, Instagram, Twitter, and LinkedIn.

About LeadingAge LTSS
The LeadingAge LTSS Center @UMass Boston conducts research to help our nation address the challenges and seize the opportunities associated with a growing older population. The LTSS Center is the first organization of its kind to combine the resources of a major research university with the expertise and experience of applied researchers working with providers of long-term services and supports (LTSS).

END

ELSE PRESS RELEASES FROM THIS DATE:

Earlier detection of cardiometabolic risk factors for kids may be possible through next generation biomarkers

2023-10-31

The next generation of cardiometabolic biomarkers should pave the way for earlier detection of risk factors for conditions such as obesity, diabetes and heart disease in children, according to a new scientific statement from the American Heart Association published in the journal Circulation. “The rising number of children with major risk factors for cardiometabolic conditions represents a potential tsunami of preventable disease for our healthcare system,” says the statement’s lead author Michele Mietus-Snyder, M.D., ...

Wearable heart monitor ticks all the boxes for better healthcare: Study

2023-10-31

A new compact, lightweight, gel-free and waterproof electrocardiogram (ECG) sensor offers more comfort and less skin irritation, compared to similar heart monitoring devices on the market. ECGs help manage cardiovascular disease – which affects around 4 million Australians and kills more than 100 people every day – by alerting users to seek medical care. The team led by RMIT University in Australia has made the wearable ECG device that could be used to prevent heart attacks for people with cardiovascular disease, including in remote healthcare and ...

Binghamton researchers get FDA approval for drug to treat world’s most common genetic disease

2023-10-31

BINGHAMTON, N.Y. -- A new drug developed by professors from the School of Pharmacy and Pharmaceutical Sciences at Binghamton University has received Food and Drug Administration (FDA) approval for the treatment of patients with Duchenne muscular dystrophy (DMD), a common genetic disease that mostly affects young boys. DMD is the most common genetic disease. It leads to the loss of the dystrophin protein in muscle tissues, with progressive weakness and challenges with day-to-day activities. The DMD gene is the largest gene in the human genome, ...

Trastuzumab deruxtecan: advantages also in HER2-low breast cancer

2023-10-31

The antibody-drug conjugate trastuzumab deruxtecan is approved for various therapeutic indications. Since March 2023, it can also be used as monotherapy for the treatment of adults with unresectable or metastatic HER2-low breast cancer who have received prior chemotherapy at this disease stage or developed disease recurrence early after adjuvant chemotherapy. Treatment with trastuzumab deruxtecan is the first approved therapy for patients with HER2-low breast cancer. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in an early benefit assessment whether the antibody-drug ...

Children with ADHD frequently use healthcare service before diagnosis, study finds

2023-10-31

Children and young people with attention deficit hyperactivity disorder (ADHD) use healthcare services twice as often in the two years before their diagnosis, a study by researchers at the University of Nottingham and King’s College London has found. The research, published today in the journal Archives of Disease in Childhood shows that children with the neurodevelopmental disorder are twice as likely to see their GP, go to hospital for an admission, and even have operations, compared to children without ADHD. The researchers say the results support the need for healthcare professionals to consider a potential diagnosis of ADHD in children who ...

The first oncogene was found more than 40 years ago. CNIO researchers have just discovered that it has a previously unknown mechanism of action

2023-10-31

In the late 1970s, the relationship between the c-Src gene and cancer was discovered. The first oncogene was identified. Since then, c-Src has been found to be overactivated in half of colon, liver, lung, breast, prostate and pancreatic tumors, but its function is not yet fully understood. CNIO researchers have now discovered that this oncogene is capable of 'self-activation', by means of a previously undescribed molecular mechanism. This finding has implications for the development of new drugs. In ...

First classification of four stages of heart attack based on heart muscle damage is released

2023-10-31

Philadelphia, October 31, 2023 – Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification of Acute Myocardial Infarction (CCS-AMI) appearing in the Canadian Journal of Cardiology, published by Elsevier, presents a four-stage classification of heart attack based on heart muscle damage. This work by a group of noted experts has the potential to stratify risk more accurately in heart attack patients and lays the groundwork for development of new, injury-stage-specific and tissue ...

New techniques efficiently accelerate sparse tensors for massive AI models

2023-10-31

Researchers from MIT and NVIDIA have developed two techniques that accelerate the processing of sparse tensors, a type of data structure that’s used for high-performance computing tasks. The complementary techniques could result in significant improvements to the performance and energy-efficiency of systems like the massive machine-learning models that drive generative artificial intelligence. Tensors are data structures used by machine-learning models. Both of the new methods seek to efficiently exploit what’s ...

The world’s first collection of brain metastasis living samples will help treat each patient with the most effective therapy for them

2023-10-31

A paper published in Trends in Cancer explains the advantages of RENACER, the world’s first repository of live brain metastases samples, created by researchers at CNIO. Live samples allow researchers to study the way cancer cells respond to drugs. This paves the way to create avatars for each individual patient to test out possible therapies before applying them. RENACER is made up of around twenty hospitals, who attended their first general assembly meeting today at the Fundación Ramón Areces, the foundation that is funding the ...

Hey, Siri: Moderate AI voice speed encourages digital assistant use

2023-10-31

UNIVERSITY PARK, Pa. — Voice speed and interaction style may determine whether a user sees a digital assistant like Alexa or Siri as a helpful partner or something to control, according to a team led by Penn State researchers. The findings reveal insights into the parasocial, or one-sided, relationships that people can form with digital assistants, according to the researchers. They reported their findings in the Journal of Business Research. “We endow these digital assistants with personalities and human characteristics, and it impacts how we interact with the devices,” said Brett Christenson, assistant clinical professor of marketing at Penn State and first author ...

LAST 30 PRESS RELEASES:

Unexpected human behaviour revealed in prisoner's dilemma study: Choosing cooperation even after defection

Distant relatedness in biobanks harnessed to identify undiagnosed genetic disease

UCLA at ASTRO: Predicting response to chemoradiotherapy in rectal cancer, 2-year outcomes of MRI-guided radiotherapy for prostate cancer, impact of symptom self-reporting during chemoradiation and mor